《大行報告》里昂上調阿里健康(00241.HK)目標價至6.4元 評級「買入」
里昂發表報告,指阿里健康(00241.HK)數週內將公佈中期業績,料其中期總收入按年升12%至129億元人民幣,通用會計準則淨利潤率料2%,調整後淨利潤則料3.2%。
該行指,阿里健康可以利用龐大且不斷增長的商家和存貨單位(SKU)基礎,來擴大其定價空間及提高黏性;公司目標今財年收入增長15%,現正步入正軌,公司或重新聚焦於淘寶,從母公司當中分享利益。該行將其目標價由5.6元上調至6.4元,維持其評級爲「買入」。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.